Show Parent

June

A harmonised European training syllabus for thoracic surgery: report from the ESTS/ERS task force group Gilbert Massard, Nathalie Tabin, Sharon Mitchell, Hasan Batirel, Alessandro Brunelli, Stefano Elia, Anna Frick, Martin Huertgen, Antoon Lerut, Laureano Molins, Kostas Papagiannopoulos, Dragan Subotic, Paul van Schil, Gonzalo Varela, Dirk van Raemdonck Eur Respir J, 51 (6) 1800370; 10.1183/13993003.00370-2018
Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension Jessica B. Badlam, Eric D. Austin Eur Respir J, 51 (6) 1801058; 10.1183/13993003.01058-2018
ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad Christophe Guignabert, Frances de Man, Marc Lombès Eur Respir J, 51 (6) 1800848; 10.1183/13993003.00848-2018
Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent Michael Kreuter, Ganesh Raghu Eur Respir J, 51 (6) 1800921; 10.1183/13993003.00921-2018
Mortality in interstitial lung disease: do race and skin colour matter? Julie Morisset, Yolanda Mageto, Ganesh Raghu Eur Respir J, 51 (6) 1800892; 10.1183/13993003.00892-2018
The ageing brain in sleep apnoea: paradoxical resilience, survival of the fittest, or simply comparing apples and oranges? David Gozal Eur Respir J, 51 (6) 1800802; 10.1183/13993003.00802-2018
Is low level of vitamin D a marker of poor health, or a cause? Om P. Kurmi Eur Respir J, 51 (6) 1800931; 10.1183/13993003.00931-2018
NO way! Nasal nitric oxide measurement in infants Jane S. Lucas, Woolf T. Walker Eur Respir J, 51 (6) 1800958; 10.1183/13993003.00958-2018
Obstructive sleep apnoea and exercise functional capacity: time to move? Núria Farré, Geraldo Lorenzi-Filho Eur Respir J, 51 (6) 1801031; 10.1183/13993003.01031-2018
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension Grayson L. Baird, Christine Archer-Chicko, R. Graham Barr, David A. Bluemke, Andrew E. Foderaro, Jason S. Fritz, Nicholas S. Hill, Steven M. Kawut, James R. Klinger, Joao A.C. Lima, Christopher J. Mullin, Pamela Ouyang, Harold I. Palevsky, Amy J. Palmisicano, Diane Pinder, Ioana R. Preston, Kari E. Roberts, K. Akaya Smith, Thomas Walsh, Mary Whittenhall, Corey E. Ventetuolo Eur Respir J, 51 (6) 1800467; 10.1183/13993003.00467-2018
A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension Anna R. Hemnes, Anandharajan Rathinasabapathy, Eric A. Austin, Evan L. Brittain, Erica J. Carrier, Xinping Chen, Joshua P. Fessel, Candice D. Fike, Peter Fong, Niki Fortune, Robert E. Gerszten, Jennifer A. Johnson, Mark Kaplowitz, John H. Newman, Robert Piana, Meredith E. Pugh, Todd W. Rice, Ivan M. Robbins, Lisa Wheeler, Chang Yu, James E. Loyd, James West Eur Respir J, 51 (6) 1702638; 10.1183/13993003.02638-2017
The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak Maeve K. Lalor, Nicola Casali, Timothy M. Walker, Laura F. Anderson, Jennifer A. Davidson, Natasha Ratna, Cathy Mullarkey, Mike Gent, Kirsty Foster, Tim Brown, John Magee, Anne Barrett, Derrick W. Crook, Francis Drobniewski, H. Lucy Thomas, Ibrahim Abubakar Eur Respir J, 51 (6) 1702313; 10.1183/13993003.02313-2017
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa Erika Mohr, Jennifer Hughes, Anja Reuter, Laura Trivino Duran, Gabriella Ferlazzo, Johnny Daniels, Virginia De Azevedo, Yulene Kock, Sarah Jane Steele, Amir Shroufi, Serge Ade, Natavan Alikhanova, Guido Benedetti, Jeffrey Edwards, Helen Cox, Jennifer Furin, Petros Isaakidis Eur Respir J, 51 (6) 1800017; 10.1183/13993003.00017-2018
The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies Tanja Tran, Samy Suissa Eur Respir J, 51 (6) 1800376; 10.1183/13993003.00376-2018
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis Ayodeji Adegunsoye, Justin M. Oldham, Shashi K. Bellam, Jonathan H. Chung, Paul A. Chung, Kathleen M. Biblowitz, Steven Montner, Cathryn Lee, Scully Hsu, Aliya N. Husain, Rekha Vij, Gokhan Mutlu, Imre Noth, Matthew M. Churpek, Mary E. Strek Eur Respir J, 51 (6) 1800255; 10.1183/13993003.00255-2018
Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities Wojciech Trzepizur, Jérôme Boursier, Marc Le Vaillant, Pierre-Henri Ducluzeau, Séverine Dubois, Samir Henni, Pierre Abraham, Christophe Aubé, Paul Calès, Frédéric Gagnadoux Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018
Sleep apnoea in the asymptomatic elderly: a real issue for the brain? Sébastien Celle, Claire Boutet, Cédric Annweiler, Jean-Claude Barthélémy, Frédéric Roche Eur Respir J, 51 (6) 1702450; 10.1183/13993003.02450-2017
Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study Yi-Qian Sun, Ben M. Brumpton, Carolina Bonilla, Sarah J. Lewis, Stephen Burgess, Frank Skorpen, Yue Chen, Tom I.L. Nilsen, Pål Richard Romundstad, Xiao-Mei Mai Eur Respir J, 51 (6) 1800329; 10.1183/13993003.00329-2018
Infant nasal nitric oxide over time: natural evolution and impact of respiratory tract infection June K. Marthin, Maria C. Philipsen, Susanne Rosthoj, Kim G. Nielsen Eur Respir J, 51 (6) 1702503; 10.1183/13993003.02503-2017
Risk factors for lung disease progression in children with cystic fibrosis Marieke van Horck, Kim van de Kant, Bjorn Winkens, Geertjan Wesseling, Vincent Gulmans, Han Hendriks, Chris van der Grinten, Quirijn Jöbsis, Edward Dompeling Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
Tobacco smoke exposure in early life and adolescence in relation to lung function Jesse D. Thacher, Erica S. Schultz, Jenny Hallberg, Ulrika Hellberg, Inger Kull, Per Thunqvist, Göran Pershagen, Per M. Gustafsson, Erik Melén, Anna Bergström Eur Respir J, 51 (6) 1702111; 10.1183/13993003.02111-2017
Understanding patients' perceptions of asthma control: a qualitative study Natalie Bidad, Neil Barnes, Chris Griffiths, Rob Horne Eur Respir J, 51 (6) 1701346; 10.1183/13993003.01346-2017
Do laboratory challenge tests for occupational asthma represent what happens in the workplace? P. Sherwood Burge, Vicky C. Moore, Alastair S. Robertson, Gareth I. Walters Eur Respir J, 51 (6) 1800059; 10.1183/13993003.00059-2018
Maternal age at delivery, lung function and asthma in offspring: a population-based survey Francisco Gómez Real, John A. Burgess, Simona Villani, Julia Dratva, Joachim Heinrich, Christer Janson, Debbie Jarvis, Jennifer Koplin, Bénédicte Leynaert, Caroline Lodge, Birger N. Lærum, Melanie C. Matheson, Dan Norbäck, Ernst R. Omenaas, Svein M. Skulstad, Jordi Sunyer, Shyamali C. Dharmage, Cecilie Svanes Eur Respir J, 51 (6) 1601611; 10.1183/13993003.01611-2016
Maximal exercise capacity in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis Monique Mendelson, Mathieu Marillier, Sébastien Bailly, Patrice Flore, Jean-Christian Borel, Isabelle Vivodtzev, Stéphane Doutreleau, Renaud Tamisier, Jean-Louis Pépin, Samuel Verges Eur Respir J, 51 (6) 1702697; 10.1183/13993003.02697-2017
What is the minimal clinically important difference for helium-3 magnetic resonance imaging ventilation defects? Rachel L. Eddy, Sarah Svenningsen, David G. McCormack, Grace Parraga Eur Respir J, 51 (6) 1800324; 10.1183/13993003.00324-2018
Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries Andrea Maurizio Cabibbe, Alberto Trovato, Maria Rosaria De Filippo, Arash Ghodousi, Laura Rindi, Carlo Garzelli, Simonetta Baretti, Guendalina Allodi, Roberta Mannino, Gian Maria Rossolini, Alessandro Bartoloni, Enrico Tortoli, Daniela Maria Cirillo Eur Respir J, 51 (6) 1800387; 10.1183/13993003.00387-2018
Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis Rudolf K.F. Oliveira, Jaquelina S. Ota-Arakaki, Paula S. Gomes, Andrea Gimenez, Carolina M.S. Messina, Roberta P. Ramos, Eloara V.M. Ferreira, David M. Systrom, Carlos A.C. Pereira Eur Respir J, 51 (6) 1800430; 10.1183/13993003.00430-2018
Effect of antifibrotics on short-term outcome after bilateral lung transplantation: a multicentre analysis Christopher Lambers, Panja M. Boehm, Silvia Lee, Fabio Ius, Peter Jaksch, Walter Klepetko, Igor Tudorache, Robin Ristl, Tobias Welte, Jens Gottlieb Eur Respir J, 51 (6) 1800503; 10.1183/13993003.00503-2018
Early experience with delamanid-containing regimens in the treatment of complicated multidrug-resistant tuberculosis in Hong Kong Kwok-Chiu Chang, Eric Chung-Ching Leung, Wing-Sze Law, Wai-Man Leung, Lai-Bun Tai, Shuk-Nor Lee, Fai-Man Lam, Chi-Hung Chau, Thomas Yun-Wing Mok, Wing-Wai Yew, Chi-Chiu Leung Eur Respir J, 51 (6) 1800159; 10.1183/13993003.00159-2018
Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era Caio Julio Cesar Fernandes, Bruna Piloto, Marcela Castro, Francisca Gavilanes Oleas, Jose Leonidas Alves, Luis Felipe Lopes Prada, Carlos Jardim, Rogerio Souza Eur Respir J, 51 (6) 1800307; 10.1183/13993003.00307-2018
Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosis Cormac McCarthy, John J. Brewington, Beth Harkness, John P. Clancy, Bruce C. Trapnell Eur Respir J, 51 (6) 1702457; 10.1183/13993003.02457-2017
Nasopharyngeal aspirate value in paediatric chronic lower respiratory tract illness Francesca Lunardi, Stefania Edith Vuljan, Egle Perissinotto, Federica Pezzuto, Sandro Malacrida, Samuela Bugin, Ilaria Bertozzi, Deborah Snijders, Stefania Rizzo, Angelo Barbato, Fiorella Calabrese Eur Respir J, 51 (6) 1701783; 10.1183/13993003.01783-2017
Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Arnaud Uguen Eur Respir J, 51 (6) 1800602; 10.1183/13993003.00602-2018
Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Sandrine Loubière, Fabrice Barlesi, Pascale Missy, Franck Morin, Pascal Auquier, Jacques Cadranel Eur Respir J, 51 (6) 1800844; 10.1183/13993003.00844-2018
A multi-organ loss of tissue phenotype in COPD: involvement of the functional muscle–bone unit Toshihiro Sugiyama Eur Respir J, 51 (6) 1800657; 10.1183/13993003.00657-2018
The association of cardiovascular autonomic dysfunction and the prediction of COPD can be explained by neurohumoral activation Stefan Andreas Eur Respir J, 51 (6) 1800737; 10.1183/13993003.00737-2018
Dysregulation of the “inflammatory reflex” with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD Fabrizio Ricci, Per Wollmer, Gunnar Engström, Artur Fedorowski, Viktor Hamrefors Eur Respir J, 51 (6) 1800806; 10.1183/13993003.00806-2018
“Number needed to treat: enigmatic results for exacerbations in COPD.” Samy Suissa. Eur Respir J 2015; 45: 875–878. Eur Respir J, 51 (6) 1452165; 10.1183/13993003.52165-2014